Introduction
Of all the mammalian TLRs characterized so far, TLR2 displays a high degree of promiscuity since PAMPs from several bacterial, viral, fungal, protozoan and helminthic pathogens, and DAMPs such as HMGB1, HSP60, HSP70 etc stimulate through TLR2 resulting in inflammatory activation of macrophages, the cellular basis of both innate immunity and inflammation 1, 2 . Polymorphisms in TLR2 gene thus determine clinical outcome of several human diseases 3 . A 23 bp insertion/deletion polymorphism in 5' UTR region of TLR2 gene reported in human populations and submitted by us to dbSNP ss181129011 https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=1 81129011 was of specific interest to us for two reasons -a) the insertion was located in chromosome 4, approximately 60 bp downstream of an NF-kB binding site, a key region regulating inflammation 4 and b) although published literature describes this polymorphism as Insertion vs Deletion in several ethnic human populations, Ins being the Correspondence: Balachandran Ravindran, Ph.D. Infectious Diseases Biology Laboratory, Institute of Life Sciences, Bhubaneswar-751 023 India; Phone: +91 674 2304204; Fax: +91 674 2300728 E-mail: balaravi@ils.res.in , ravindran8@gmail.com dominant allele, a search of database revealed that the 23bp insertion in the 5' UTR region of TLR2 gene was unique and found only in primates and not in rodents and other mammals. More interestingly, in lower primates such as rhesus, nomascus monkeys, baboons etc insertion of one copy of the 23bp sequence was observed and in higher primates viz., Orangutans and Chimpanzees two copies were found to be inserted while in Gorilla three copies were found (summarized in Figure 1a) . In the present study we set out to a) validate these insertion polymorphism in wild primates, and b) test in vitro response of human mononuclear cells with Indel polymorphism on stimulation with several TLR2 ligands, and c) to study the status of inflammatory response in patients with severe malaria to correlate the TLR2 Indel polymorphism with disease outcome.
MATERIALS AND METHODS Ethics statement
Human blood samples from healthy controls (laboratory volunteers) and P.falciparum infected patients were collected using standardized Institutional protocol approved by Human ethical committee of Institute of Life Sciences, P a n d a e t a l .
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Bhubaneswar. Written informed consent was obtained from each of study participants or accompanying persons in the case of children and patients in comatose state.
Healthy controls
123 healthy laboratory volunteers from Institute of Life Sciences and Regional Medical Research Centre, Bhubaneswar, India were enrolled. About 50ul of blood was collected by finger prick and genomic DNA was purified using a kit according to manufacturers' instructions (Sigma). All individuals were genotyped for TLR2 (23bp ins/del), TLR2 codon (Arg677Trp, Arg753Gln), TLR4 (Asp299Gly, Thr399Ile) and TLR1 (I602S) polymorphisms as described below. To avoid confounders of activation by TLR2 ligands only those healthy subjects with wild type TLR4 and TLR1 polymorphism were used to investigate phenotype differences between 23bp Indel polymorphism.
Detection of TLR2 (23bp ins/del, Arg753Gln and Arg677Trp) polymorphisms
All subjects were genotyped for TLR2 (23bp ins/del) polymorphism by polymerase chain reaction as described earlier 5 . In brief, following primers were used for (23bp ins/del) genotyping: sense 5′-CACGGAGGCAGCGAGAAA-3' and anti-sense 5′-CTGGGCCGTGCAAAGAAG-3'. PCR was carried out in a total reaction volume of 20 μ L containing about 200 ng genomic DNA, 10 pmol each primer, 200 ng each dNTP and 1 U Taq DNA polymerase (sigma). The thermo-cycling condition was as follows: initial denaturation for 5 min at 95°C, followed by 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s. The final extension step was prolonged to 7 min at 72 0 C. PCR products were separated on 3% agarose gel electrophoresis and visualized in gel documentation system after ethidium bromide staining. A single band at 286 bp was classified as wild type (Ins/Ins), a single 263-bp band as homozygous mutation (Del/Del), and those displaying two bands of 286bp and 263bp were as heterozygous mutation (Ins/Del). Randomly chosen PCR products were purified using Qiagen PCR Purification System (Qiagen, UK) and sequenced using an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA) and Big Dye Terminator DNA sequencing kit (Applied Biosystems). Distributions of two TLR2 polymorphisms (Arg753Gln, Arg677Trp) samples were genotyped by PCR followed by restriction fragment length polymorphism (RFLP) according to an earlier report 6 . Primers: Forward 5′-GCCTACTGGGTGGAGAACCT-3′ and Reverse; 5′-GGCCACTCCAGGTAGGTCTT-3′were used to amplify a region of 340 bp including both polymorphisms (Arg753Gln, Arg677Trp) by following conditions: 94 0 C for 5 min, then 30 cycles of 94 0 C for 30 sec, 58 0 C for 30 sec, and 72 0 C for 30 sec. The amplicons were digested overnight with AciI and analyzed by agarose gel electrophoresis. Amplified products were randomly sequenced for confirmation of individual's genotype.
Determination of TLR2, TLR4, TLR5 and TLR9 expression on circulating human monocytes
The TLR2 expression on cell surface was determined by flow cytometry using two-color immunofluorescent technique in 48 healthy laboratory volunteers: 27 ins/ins individuals, 16 subjects of ins/del and 5 subjects of del/del type were included for analysis. Briefly, 50ul of whole blood were directly stained for 30 min at 4 °C with a combination of fluorochrome-conjugated mAbs: phycoerythrin (PE)-labeled anti-TLR2 (Imgenix), fluorescein-isothiocyanate (FITC)-labeled anti-CD14 (eBiosciences). Appropriate isotype controls (eBiosciences) were also used. were lysed using FACS lysis solution (BD Biosciences, USA) and the cells were washed with washing buffer followed by centrifugation at 300 × g for 5 min. The cell pellet was then re-suspended in 500 μ l of sheath fluid and analysed flow cytometry in FACS caliber. Expression of TLR4, TLR5 and TLR9 on monocytes was quantified in 10 subjects with ins/ins and 10 with ins/del. About 50ul of whole blood was stained with anti-CD14-FITC and anti-TLR4-PE (eBiosciences) or TLR5-PE (Santacruz), expression was analysed as described above by FACS. For TLR9 staining, cells were labeled with anti-TLR9-FITC (eBiosciences) and a membrane marker anti-CD14-PE (eBiosciences), fixed and permeabilized, and analysed by flow cytometry.
Genotyping of TLR4 (Asp299Gly, Thr399Ile) and TLR1 (I602S) polymorphisms
Genomic DNA of all healthy lab volunteers were analyzed for TLR4 (Asp299Gly, Thr399Ile) and TLR1 (I620S) polymorphisms. Genotyping of TLR4 Asp299Gly polymorphism was carried out by allele specific PCR. Two forward primer (allele specific discrimination at the 3' end) 5'-CTTAGACTACTACCTCGATGA-3' (wild), and 5'-CTTAGACTACTACCTCGATGG-3' (mutant), with a common anti-sense Reverse Primer-5'-TAAGCCTTTTGAGAGATTTGA-3' were used and PCR was performed as follows: 12 cycles of 10 seconds at 95 0 C followed by 60 seconds at 65 0 C, followed by 17 cycle of 10 seconds at 95 0 C, 50 seconds at 60 0 C and 30 seconds at 72 0 C. The final extension was for 7 min at 72 0 C. β -actin primers were taken as internal controls. The amplified products (192bp) were analyzed by electrophoresis on 2.5% agarose gels stained with ethidium bromide. DNA from normal subjects will get amplified with 'wild type' primersheterozygous mutations will be characterized by amplification with both 'wild type' as well as 'mutation' specific primers. DNA from individuals homozygous for TLR4 mutations will get amplified only with mutant specific primer. TLR4 Thr399Ile polymorphism was detected by PCR amplification of involved region with sense primer 5'-GCTGTTTTCAAAGTGATTTTGGGAGAA-3' that contains a mismatch at position -3 from the 3' end of the primer (G instead of C) to create a Hinf I cleavage site when the mutant allele is amplified. Antisense primer was 5'-CACTCATTTGTTTCAAATTGGAATG-3'. The parameters were an initial denaturation at 95°C for 7 min, followed by 35 cycles: denaturation at 95°C for 30 s, annealing at 62°C for 30 s, and elongation at 72°C for 32 s. The final elongation was at 72°C for 5 min followed for a cooling to 4°C. The amplicon of 147-bp length were digested at 37°C with Hinf I for 4 hrs resulting in fragments that either were cut into two fragments of 122-bp and 25-bp (mutant allele) or were not restricted (wild allele). These fragments were analyzed by electrophoresis on 3% agarose gels stained with ethidium bromide. PCR-RFLP technique P a n d a e t a l . 3 was also employed to determine variation in codon 602 of TLR1 gene. A fragment containing exon 4 of TLR1 was amplified from genomic DNA using the following PCR primers: forward, CTTGATCTTCACAGCAATAAAATAAAGAGCATTCC, and reverse, GGCCATGATACACTAGAACACACATCACT. The PCR conditions were an initial denaturation at 95°C for 5 min, followed by 32 cycles: denaturation at 95°C for 30 s, annealing at 60°C for 30 s, and elongation at 72°C for 32 s. The final elongation was at 72°C for 5 min. The amplicon was digested by PstI to discriminate between the TLR1 602 alleles.
TLR2 GT repeats typing
To amplify a region of about 150 base pairs flanking the microsatellite GT repeat, We performed PCR using the FAM-labeled primer (forword-FAM-5'-TATCCCCATTCATTCGTTCCATT-3') and a reverse primer (5'-GACCCCCAAGACCCACACC-3') (Integrated DNA technologies, Iowa USA). The thermal cycler conditions were as follows: preheating at 94 0 C for 5 minutes, followed by 35 cycles of 94 0 C for 30 seconds, 58 0 C for 30 seconds, and 72 0 C for 30 seconds; and then a final extension of 5 minutes at 72 0 C. The numbers of GT repeats were determined by sizing the PCR products using an ABI 310 sequencer (Applied Biosystems, Foster City, CA) and Genescan analysis 2.1 software (Applied Biosystems). For all primates, same primer set were used for typing of TLR2 microsatellite GT repeats.
Isolation and stimulation of monocyte
About 5 ml of whole venous blood were collected from pregenotyped healthy lab volunteers that include: seven ins/ins individuals, seven subjects of ins/del genotype and five homozygous del/del individuals. All subjects enrolled for functional study with ins/ins, ins/del or del/del genotypes were wild type for TLR4 (Asp299Gly and Thr399Ile) and TLR1 (I602S) polymorphisms. 5 ml of blood was layered onto 5 ml of HISTOPAQUE-1077 (Sigma) and centrifuged at 400 g for 30 min in room temperature. Peripheral blood mononuclear cells were removed from the interface and washed twice (10 min, 250 g) in culture medium before being counted. Cells were resuspended to 10 6 cells per ml in Dulbecco's Modified Eagle Medium (DMEM) with 1% antibiotics (Penicillin Streptomycin solution from Sigma) and 10% fetal bovine serum. Cells were placed in a 96 well culture plate (100ul per well) and incubated in a 5% CO2 incubator at 37 0 C for 4 hours. Non adherent cells were removed by rinsing of medium thrice. Adherent cells were stimulated with wide range of TLR2 agonists: Peptidoglycan from Streptomyces species, Methanobacterium species, Saccharomyces cerevisiae, Micrococcus luteus, Bacillus subtilis, and Staphylococcus aureus (100ug/ml), all obtained from Sigma. Synthetic TLR2 agonist Pam3CSK44 (1ng/ml) from IMGENIX, Vi polysaccharide (20ug/ml) from GlaxoSmithKline and γ -irradiated Mycobacterium tuberculosis (1X10 6 /ml). LPS was taken as positive control (10ug/ml) (Sigma) and monocytes were stimulated with CpG (10ug/ml), Poly IC (10ug/ml) and flagellin (100ug/ml) as negative control. LPS contamination was minimized by addition of 10ug/ml of polymixin-B to the culture medium except positive control well (LPS 10ug/ml Sigma). After 48 hours of incubation supernatant were collected and stored at -80 0 C until assays for cytokine. Primates DNA:
.
. F e c a l 
P. falciparum malaria patients
P. falciparum infected subjects were enrolled at SCB Medical College and Hospital, Cuttack, Odisha. The area is highly endemic for malaria with more than 85% of malaria cases attributed to P. falciparum. Patients enrolled in the current study are residents of coastal districts in India which are highly endemic for P.falciparum malaria -average Annual parasite index (API) of P falciparum was 6.67 (http://nvbdcp.gov.in/Doc/malaria_situation_april12.pdf). Clinically suspected malaria patients were screened for P. falciparum infection by Giemsa-stained thick and thin blood smears and immune chromatography test (SD Bio Standard Diagnostics India). Detection of P. falciparum was also performed by nested polymerase chain reaction (PCR) 7 . P. falciparum infected individuals were categorized based on WHO guidelines. The inclusion criteria for uncomplicated malaria (UM) cases were symptoms of fever with evidence of P. falciparum infection in the blood. Severe malaria (SM) patients were categorized into three groups based on distinct clinical features: 1) Cerebral malaria (CM), 2) Non cerebral severe malaria (NCSM) and 3) Multi-organ-dysfuction (MOD) as described in our earlier reports 7, 8 . About 5ml of venous blood was collected in EDTA vials from all enrolled patients. Plasma was separated a stored at -80 0 C until further use.
C-reactive protein (CRP) and Cytokines (TNF-α, IL1β) assays P a n d a e t a l . 4 Plasma CRP of healthy lab controls and P.falciparum infected patients were quantified by quantitative immunoturbidometric assays according to manufacturer's instructions (Labkit, Merck, Millipore). Enzyme linked immunosorbent assay (ELISA) was employed for quantification of plasma TNF-α from healthy lab controls and falciparum infected patients according to manufracturer instructions (ebiosciences). IL1β levels in culture supernatant were also quantified by bioplex (Biorad) or ELISA kit (ebiosciences). 
Statistical analysis

Results:
We tested the 23 bp TLR2 polymorphism in 4 rhesus monkeys, 3 baboons, 25 Chimpanzees and 8 Gorilla using fecal DNA samples to validate gene sequences reported in NCBI data-base --all the 25 Chimpanzees were homozygous for 'del' allele and 1 of the 8 Gorilla was heterozygous while the other 7 displayed homozygous double 'Insertion' (Figures 1b, 1c and 1d) . In general polymorphism observed by us was consistent with sequences reported in the database. A closer examination with rodent TLR2 gene sequence revealed that expression of 23bp 'insertion' and 'deletion' widely being reported by investigators in literature in humans and in the data base is a misnomer -the polymorphism is essentially absent in TLR2 5' UTR region of rodent genes and lower primates seem to have acquired one copy since downstream of the 23bp 'insertion' a similar 23 bp sequence is found in rhesus monkeys, nomascus monkeys and baboon which are otherwise classified as 'deletion' in literature (fig 1a) . Thus what has been designated as 'deletion' in lower primates in reality is 'insertion' when compared with 5' UTR region gene of mice TLR2. In higher primates such as Chimpanzee and Organgutan the 23 bp sequence is found duplicated once and Gorilla TLR2 gene displays three copies of 23 bp insertion. The 'insertion' event in lower primates appears to have been positively selected during primate evolution. In this manuscript for the sake of consistency with literature we continue to use the terminology currently being used viz., 'deletion' and 'insertion' of 23bp sequence of TLR2 gene.
In a cohort of 432 normal healthy Indian adult population prevalence of 'del' allele was found to be about 14% -the frequency of 'del' polymorphism in other geographical areas varied from 13% in PNG to 36% in Northern Han Chinese. (Table 1) . Normal healthy human volunteers with 'del' allele expressed significantly more surface TLR2 on monocytes in comparison to those with 'ins' allele (Fig 2a) and also displayed elevated plasma TNF-α and CRP levels, (although at physiologically normal levels -Fig 2b & 2c) . A significant positive correlation was found between plasma levels of TNF-α and CRP (Fig 2d) . These findings suggested a significant association between 'del' allele of TLR2 gene and bio-markers of systemic inflammation even in normal healthy adults. We tested the significance of this observation in vitro by directly activating human mononuclear cell ex vivo with TLR2 ligands. We stimulated normal human PBMCs with Pam3CSK4 and Vi polysaccharide of Salmonella typhi 9 and quantified cytokines in culture supernatants. Subjects with 'del' allele secreted higher levels of IL-6, IL-1β, TNF-α and IL10 in comparison to those with ins/ins genotype (Figure 3 a,b,c,d ). There was no significant difference between the two groups when stimulated with CpG DNA, a TLR9 ligand. For further confirmation a larger panel of TLR2 ligands was used for stimulation of normal PBMCs ex vivo. About 4 to 7 fold enhanced secretion of IL-1b was observed in subjects with 'del' allele when stimulated with Pam3CSK4 and Vi polysaccharide, peptidoglycan (PGN) from 6 different microbial source or γ -irradiated Mycobaterium tuberculosis (Figure 3e ), suggesting propensity of 'del' subjects to respond more vigorously to TLR2 ligands. The observed difference was specific to only TLR2 since TLR4, TLR5 and TLR9 expressions were comparable in all the subjects (data not shown) and levels of IL-1b secretion was similar in both the groups when stimulated with poly IC, flagellin or CpG DNA (Figure 2e ). We conclude that normal humans with 'del' allele in TLR2 gene display higher levels of plasma TNF-α and CRP and their PBMCs get activated more vigorously when stimulated with TLR2 ligands.
Since insertion of 23bp sequence in TLR gene is observed only primates and not in lower animals such as mice, we addressed the issue of significance of this insertion during primate evolution. 'Malaria hypothesis' widely reported in literature attributes severe P. falciparum for selection of a variety of haemoglobinopathies reported in human population 10 . Secondly, malarial glycolsylphosphatidylinositol (GPI), a TLR2 ligand has been proposed as a 'malaria toxin' that induces inflammatory activation of monocytes/macrophages and is reported to mediate systemic inflammation and play a role in mediating severe clinical manifestations observed in malaria 11, 12 . Based on this logic malarial GPI has also been tested as a candidate anti-disease vaccine for malaria 13 . We hypothesized that malaria could have offered survival advantage in patients with insertion allele of 23bp sequence in their TLR2 gene that leads to decreased inflammatory response thus contributing to lower inflammatory response, lesser clinical severity and mortality caused by malaria. To test our hypothesis we enrolled 398 malaria patients with different grades of clinical severity viz., un-complicated malaria (UM), cerebral malaria (CM), multi organ dysfunction (MOD) and non-cerebral severe malaria (NCSM) 7 (Table 2 ) and genotyped TLR2 indel polymorphism in 356 patients (Table 3) . Patients with 'del' allele displayed predilection for development of severe malaria (Table 3 ) and increased P a n d a e t a l .
5 mortality (Table 4) . Plasma TNF-α and CRP levels correlated positively with clinical severity (Fig 4a and 4b) as well as mortality (Fig 4c and 4d ) in the cohort of malaria patients analyzed in the study, confirming earlier reports of direct correlation between increased inflammation and adverse prognosis in malaria 14, 15 . More crucially, increased plasma TNF-α and CRP levels in our patients correlated very significantly with TLR2 genotype -patients with 'del' allele were found to be high producers of TNF-α and CRP (Fig 5a  and 5b respectively) in comparison to those homozygous for 'ins' allele, suggesting significant association between this TLR2 polymorphism and enhanced systemic inflammation and clinical severity in human P. falciparum malaria. This association was found to be consistent for each of the clinical groups analyzed for plasma TNF-α levels (Fig 5c  respectively) . Polymorphism of TNF-α genes and its association with enhanced TNF-α levels and clinical severity have been reported 16 -in comparison our observations on TLR2 'del' polymorphism in adult population and its association with plasma TNF-α levels, clinical severity and mortality appears to be most compelling. Another polymorphism viz., GT repeat microsatellite in intron2 of TLR2 gene has been earlier shown to determine TLR2 mediated inflammation in humans -larger the number of GT repeats lesser is the inflammatory response to TLR2 ligands 17, 18 . Such GT repeats are absent in lower primates and higher primates display GT repeats 19 . We typed our cohort of malaria patients to investigate possible relationship between GT repeat polymorphism and plasma TNF-α and CRP levels. There was no significant association between GT repeat polymorphism and plasma levels of TNF-α and CRP (Fig 6a and 6b respectively) . When TLR2 23bp polymorphism and GT repeats were combined and analyzed together, patients with 'del' allele were found to have significantly more TNF-α and CRP in patients regardless of short or long GT repeats in TLR2 gene (Fig 6c and 6d respectively)
Discussion
The current study has offered several novel insights in the context of a TLR-2 polymorphism, evolution of TLR-2 in primates and susceptibility to TLR2 mediated inflammation in human malaria. First, 'deletion' of a 23bp nucleotide sequence in TLR-2 observed only in lower primates (Rhesus monkey, Baboon, Marmoset and Nomascus) and not in higher primates (Chimpanzees, Gorilla, Orangutan and Neanderthal) as reported in literature was found to be a misnomer -in comparison with mouse TLR2 gene, the 23bp insertion sequence already exists in the 5' UTR region in lower primates that are otherwise designated as 'deletion' in literature. Lower primates seems to have acquired the insertion which appears to have been duplicated further in higher primates viz., Chimpanzees, Orangutan and Gorilla. Distribution pattern of TLR23bp ins/del polymorphism (as reported in database) were confirmed by us by studying 4 rhesus monkeys, 3 baboons, 8 Gorillas and 25 Chimpanzees collected from the wild. Based on very high prevalence of asymptomatic malaria (analogous to asymptomatic infections in malaria endemic human population) in wild Chimpanzees and Gorilla 20 and two and three 23bp 'insertion' sequences respectively in Chimpanzee and Gorilla we propose that malaria may have offered evolutionary pressure to select 'Ins' allele of TLR2 gene in primates. We sought evidence for this proposal by studying a large cohort of malaria patients since 'Malaria hypothesis' widely reported in literature attributes severe P. falciparum infections in human communities for selection of a variety of haemoglobinopathies 10 . Secondly, malarial glycosylphosphatidylinositol (GPI), a TLR2 ligand has been proposed as a 'malaria toxin' that induces inflammatory activation of monocytes/macrophages and responsible for severe clinical manifestations observed in malaria 11, 12 . Based on this logic malarial GPI has also been tested as a candidate anti-disease vaccine for malaria 13 . We hypothesized that severe malaria could have offered evolutionary pressure needed for selecting 'ins' allele in TLR2 gene in higher primates leading to decreased inflammation and contributing to lower clinical severity and mortality caused by P. falciparum malaria. Reports in literature offer credence to this view. Chimpanzees and Gorilla have restricted natural habitat with small population size and about 40-50% of wild chimpanzees and gorillas have been found infected (analogous to asymptomatic infection status in humans) with P. falciparum 'like' malarial parasites 20, 21 .
On the contrary, severe malaria such as cerebral malarial anemia, multi-organ failure are common cause of high mortality in human P. falciparum malaria 22 mediated by induction of inflammatory cytokine storm particularly high TNF-α levels 10, 15 . To test our hypothesis we enrolled 398 malaria patients with different grades of clinical severity viz., un-complicated malaria (UM), cerebral malaria (CM), multi organ dysfunction (MOD) and noncerebral severe malaria (NCSM) 7 and genotyped TLR2 ins/del polymorphism in 356 patients. Patients with 'del' allele displayed increased predilection for development of severe malaria and mortality. Inflammatory cytokine storm and high levels of plasma TNF-α have been attributed to development of pathology leading to bad prognosis in severe malaria 10, 15 . In the cohort of malaria patients studied by us, we observed a significant positive association between high TNF-α levels and clinical severity: patients with MOD displayed the highest levels, followed by NCSM and CM. Plasma TNF-α levels were significantly more in patients who succumbed to severe malaria when compared to survivors, corroborating with earlier reports 10, 15, 23 . While the role of very high levels of TNF-α in shock and organ failure leading to mortality has been known 23 the role of CRP in P. falciparum malaria is poorly documented in literature. CRP has been shown to bind to infected erythrocytes and clear damaged RBCs from circulation which possibly leads to anemia 24, 25 . Further, high levels of CRP has been related with parasite density and malarial severity 26 . The more significant and novel findings of the current study is significant association observed between elevated plasma levels of TNF-α and CRP with the TLR2 Indel genotype -patients with 'del' allele were found to be high producers of TNF-α and CRP in comparison to those with 'ins' allele, suggesting that patients with 'deletion' of 23bp sequence of TLR2 gene are prone to enhanced systemic inflammation and higher clinical severity when they get infected with P. falciparum malaria. Polymorphism of TNF-α genes and its association with enhanced TNF-α levels and clinical severity has been reported 16 -our P a n d a e t a l . 6 observations on TLR2 'del' polymorphism in adult population and its association with TNF-α levels as well as clinical severity and mortality appears most compelling. Since we found 'ins' allele consistently in higher primates in the wild (a large population of which harbor malarial parasites in circulation) and association of 'del' allele with increased clinical severity and mortality in humans with P. falciparum, we propose that malaria could have offered evolutionary pressure for selection of the 23 bp sequence in TLR-2 genes in higher primates thus offering them survival advantage.
While analyzing several wild primates we found consistent presence of 'del' allele in all lower primates and absence of 'del' allele in all Chimpanzees and Gorilla. It is not clear to us currently how about 20% of humans display 'del' allele in several ethnic human populations. Our investigations do not however rule out complete absence of 'del' allele in higher primates since we have tested only a limited number of Chimpanzees and Gorilla that had survived selection under wild forest conditions. The other possibility, less likely, is that occurence of 'del' allele in about 20% of humans suggests that selection due to severe forms of malaria may have diminished in early humans due to absence of severe malaria leading to loss of 'ins' alleleit has been argued that emergence of severe P. falciparum malaria is a more recent evolutionary event 27, 28 . It has been also been proposed that early homo sapiens lost their ability to synthesize N-Glucoryl neuraminic acid and consequently became resistant to P. reichnowi (malarial parasites infecting Chimpanzees) until emergence of P. falciparum, that uses N-Acetyl neuraminic acid as its receptor 28 . Based on genetic analysis of several strains of P. falciparum, mosquito biting behavior and emergence of haemoglobin disorders selected by P. falciparum in Africa it has been suggested that virulent P. falciparum may have emerged in human population only about 5000-10000 years ago as a consequence of introduction of agrarian practice 27 . The possibility that PBMCs with 'del' allele are prone to enhanced activation by TLR2 ligands was also tested. Stimulation of PBMCs of normal healthy volunteers with TLR-2 ligands such as PAM3CSK4, peptidoglycans from several bacterial species, Vi polysaccharide of Salmonella typhi etc revealed that subjects with 'del' allele respond more vigorously releasing significantly high levels of IL-1β, IL-6 and TNF-α when compared to those with 'ins' allele. These findings are in contrast to two earlier reports using experimentally transfected cell lines and scoring luciferase activity 29,30 -we attribute this to possible experimental artifacts while using cell lines for studying functional activation of immune cells. Similar discrepancy between transfection-based functional analysis and in vivo response has been reported for TIRAP S180L polymorphism 31 . We conclude that transfection-based experiments need to be interpreted with caution while correlating genotypes with phenotypes.
Another polymorphism in intron 2 region of TLR2 gene GT repeat microsatellite has been shown to determine TLR2 mediated inflammation in humans -larger the number of GT repeats lesser is the inflammatory response to TLR2 ligands 18 . In the present study, no significant association of TLR2 GT repeats with plasma TNF-α and CRP was observed. Combined analysis of 'del' allele and GT repeat of TLR2 revealed that 'del' allele plays a more important role in induction of increased TNF-α and CRP levels in malaria than GT repeat polymorphism. More significantly, combined distribution of 23bp ins/del and GT repeat polymorphism reveled that larger GT repeats (reported to be less inflammatory) are linked to 'ins' allele. Our observation of absence of such GT repeats in lower primates and presence only in higher primates, not only confirms the previous report 19 but also supports the notion that decreased TLR2 mediated inflammation is linked to primate evolution. Regardless of malaria contributing to positive selection and emergence of 'ins' allele of TLR2 gene in higher primates, the observation that humans with 'del' allele are prone to increased TLR2 mediated inflammation has opened up avenues for future investigations on innate immunity/ inflammation in humans. Both innate as well as adaptive immune responses are directly influenced by TLR-2 mediated activation of dendritic cells and T lymphocytes [32] [33] [34] and thus 'ins' vs 'del' in TLR2 gene could influence host response and susceptibility of humans to several other diseases such as HIV-AIDS 35 , H. pylori mediated gastric cancer 36 and Alzheimer's disease 37 .
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